Goldman Sachs’s Cogent Biosciences COGT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$8.62M Buy
1,200,437
+211,475
+21% +$1.52M ﹤0.01% 2374
2025
Q1
$5.92M Buy
988,962
+124,069
+14% +$743K ﹤0.01% 2617
2024
Q4
$6.75M Sell
864,893
-13,144
-1% -$103K ﹤0.01% 2628
2024
Q3
$9.48M Buy
878,037
+364,290
+71% +$3.93M ﹤0.01% 2307
2024
Q2
$4.33M Sell
513,747
-357,450
-41% -$3.01M ﹤0.01% 2715
2024
Q1
$5.85M Buy
871,197
+424,425
+95% +$2.85M ﹤0.01% 2446
2023
Q4
$2.63M Buy
446,772
+46,890
+12% +$276K ﹤0.01% 3036
2023
Q3
$3.9M Buy
399,882
+35,048
+10% +$342K ﹤0.01% 2655
2023
Q2
$4.32M Sell
364,834
-188,896
-34% -$2.24M ﹤0.01% 2670
2023
Q1
$5.97M Sell
553,730
-92,007
-14% -$993K ﹤0.01% 2396
2022
Q4
$7.46M Sell
645,737
-96,251
-13% -$1.11M ﹤0.01% 2340
2022
Q3
$11.1M Buy
741,988
+372,063
+101% +$5.55M ﹤0.01% 2048
2022
Q2
$3.34M Buy
369,925
+190,892
+107% +$1.72M ﹤0.01% 3020
2022
Q1
$1.34M Buy
179,033
+99,874
+126% +$748K ﹤0.01% 3896
2021
Q4
$679K Sell
79,159
-70,534
-47% -$605K ﹤0.01% 4304
2021
Q3
$1.26M Buy
+149,693
New +$1.26M ﹤0.01% 3817
2021
Q2
Sell
-38,882
Closed -$341K 5379
2021
Q1
$341K Buy
38,882
+28,569
+277% +$251K ﹤0.01% 4567
2020
Q4
$116K Buy
10,313
+2,188
+27% +$24.6K ﹤0.01% 4447
2020
Q3
$76K Sell
8,125
-2,305
-22% -$21.6K ﹤0.01% 4267
2020
Q2
$19K Hold
10,430
﹤0.01% 4311
2020
Q1
$17K Sell
10,430
-1,154
-10% -$1.88K ﹤0.01% 4365
2019
Q4
$33K Sell
11,584
-14,290
-55% -$40.7K ﹤0.01% 4230
2019
Q3
$149K Buy
25,874
+11,227
+77% +$64.7K ﹤0.01% 3991
2019
Q2
$153K Buy
14,647
+10,664
+268% +$111K ﹤0.01% 3935
2019
Q1
$70K Sell
3,983
-1,373
-26% -$24.1K ﹤0.01% 4057
2018
Q4
$94K Buy
5,356
+2,205
+70% +$38.7K ﹤0.01% 3896
2018
Q3
$130K Sell
3,151
-4,760
-60% -$196K ﹤0.01% 3900
2018
Q2
$454K Sell
7,911
-5,538
-41% -$318K ﹤0.01% 3564
2018
Q1
$598K Buy
+13,449
New +$598K ﹤0.01% 3412